The landmark series: desmoid : continuing education - sarcoma

Desmoid-type fibromatosis represents a challenge in the landscape of surgical oncology, for several reasons. The tumors can be infiltrative and locally aggressive, surgery may be morbid, and patients are usually young, and thus treatment sequelae must be managed for decades. Desmoids do not have met...

Full description

Saved in:
Bibliographic Details
Main Authors: Fiore, Marco (Author) , Crago, Aimee (Author) , Gladdy, Rebecca (Author) , Kasper, Bernd (Author)
Format: Article (Journal)
Language:English
Published: 01 January 2021
In: Annals of surgical oncology
Year: 2021, Volume: 28, Issue: 3, Pages: 1682-1689
ISSN:1534-4681
DOI:10.1245/s10434-020-09395-5
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-020-09395-5
Get full text
Author Notes:Marco Fiore, Aimee Crago, Rebecca Gladdy, and Bernd Kasper
Description
Summary:Desmoid-type fibromatosis represents a challenge in the landscape of surgical oncology, for several reasons. The tumors can be infiltrative and locally aggressive, surgery may be morbid, and patients are usually young, and thus treatment sequelae must be managed for decades. Desmoids do not have metastatic potential, therefore management strategies for desmoids have evolved to employ frontline treatments that are largely non-operative. In fact, with unpredictable and benign behavior, we now recognize that desmoids can also stabilize and regress, making active observation an option for many patients. Moreover, many medical therapies are active in the disease. We reviewed landmark studies describing contemporary issues that affect treatment recommendations for desmoid patients: prognostic factors, indication to active surveillance, role of surgical margins, postoperative radiotherapy, and the most recent expert consensus papers.
Item Description:Gesehen am 19.08.2021
Physical Description:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-020-09395-5